Batavia Biosciences

🌟 Ever wondered where all the magic happens? 🌟 Discover our headquarters in Leiden and learn about our work! At Batavia Biosciences, we're pioneers in contract manufacturing and development organization (CDMO) services, offering cutting-edge solutions to biotechnological challenges. Step into our Leiden location, a thriving center of innovation where our dedicated team works tirelessly to provide top-notch services. Immerse yourself in our world of biotechnology and discover our unwavering commitment to scientific excellence for gene therapy. 🧬 Watch the video of Doe Maar Duurzaam (VTM) for a sneak peek into our operations! (You can activate subtitles in your language by clicking the "CC" button on the bottom right of the video.) 🎥https://lnkd.in/eeThRtCT #BataviaBiosciences #Leiden #CDMO #Biotechnology #Innovation #scientificQuality #DoeMaarDuurzaam #Viralvectors #viralvaccines #genetherapy #celltherapy Ahd Hamidi Wilfried Bakker Marije Turk

We're pleased to share that Batavia Biosciences recently participated in the renowned #Immuno2024 conference in London, a testament to our ongoing commitment to advancing biotech innovation within the industry.🚀🔬 🎤 Our Senior Scientist DSP, Manas Sahoo, delivered an insightful presentation, highlighting our dedication to driving pharma innovation forward. Check out this snapshot from the event! 📸Stay tuned for more insights and updates from the biotech world. 📸 Photo 1-2 courtesy of Rizwan Chaudhrey 💡 #Immuno2024 #BiotechLeaders #BataviaBiosciences #cdmo #viralvectors #viralvaccine #conference #biotechinnovation #pharmainnovation #vaccines Danielle Trappenburg - Eelkman Rooda Pieter-Jan Vos

🌟 Celebrating Diversity in Leadership: Insights from the WomenLift Health Global Conference 2024! 🌟 At Batavia Biosciences, we are proud to share a significant step forward in our commitment to gender equality and empowerment. Recently, one of our representatives had the privilege to attend the prestigious WomenLift Health Global Conference 2024 in Tanzania, sponsored by the Bill & Melinda Gates Foundation (BMGF). https://lnkd.in/gnHWFUXr Batavia Biosciences was honored to be selected by BMGF as one of their grantees to participate in this enlightening event. Our Strategic Partnership Director, Ahd Hamidi, shared her invaluable experience: "I had the possibility to network and get insights from the different workshops provided, which I can directly apply to my daily work management practices." The conference sparked insightful discussions on a multitude of topics, ranging from the utilization of AI in Global Health to effective conflict management strategies and beyond. But beyond the enriching discussions, this conference reinforced our belief in the importance of having women in leadership roles. Here's why: 🌗 Diverse Perspectives: Women bring unique viewpoints and experiences to the table, enriching our decision-making processes and fostering innovation. 🤝 Enhanced Collaboration: Gender-diverse leadership teams promote collaboration and open dialogue, leading to more comprehensive solutions to complex challenges. 🚀 Better Business Performance: Studies consistently show that companies with gender-diverse leadership teams outperform their peers, highlighting the tangible benefits of diversity in driving business success. 😎 Role Modeling and Mentorship: Women leaders serve as inspiring role models and mentors, paving the way for future generations of aspiring professionals. 🏆Reflective of Customer Base: In the healthcare industry, women make up the 70% of the workforce, a predominant part of the customer base. Having women in leadership positions allows for a better understanding and service of the needs of the client base. Why else is it important to have women leadership in this sector? This is a question we address to you. 👈 Join us as we celebrate the power of diversity in leadership and continue our journey towards a brighter, more equitable future! #BataviaBiosciences #WomenInLeadership #healthcare #leadership #customergoal #Inclusion #Empowerment #Innovation #GenderEquality #WomenLiftHealth

🌟 Exciting News Alert! 🌟 Batavia Teams Up with ChromaTan, Inc to Revolutionize AAV Manufacturing! 🚀🔬 We are thrilled to announce this alliance between Batavia and ChromaTan, fueled by a prestigious grant from NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals 🎉 To improve AAV manufacturing, we will integrate ChromaTan's column-free continuous chromatography (BioRMB™ ) into our HIP-Vax® manufacturing platform for AAV. This collaboration underscores our commitment to advancing biopharmaceutical manufacturing while reducing costs and environmental impact through process intensification. 🌱💊 The demand for recombinant adeno-associated virus (rAAV) vectors is skyrocketing as they pave the way for revolutionary treatments. Yet, the current production capacity struggles to keep pace. With continuous chromatography already revolutionizing monoclonal antibody manufacturing, we're determined to apply the same principles to rAAV production. 💡 ChromaTan's BioRMB™, a column-free real moving bed continuous chromatography platform, promises to be a game-changer. By seamlessly integrating it into our HIP-Vax® platform, we aim to not only boost manufacturing efficiency but also tackle the global shortage of rAAV. 🌍💉 Stay tuned as we embark on this journey towards revolutionizing AAV manufacturing! 🌐💪 Full press release: https://zurl.co/oT4z #BiopharmaInnovation #AAVManufacturing #ProcessIntensification #NIIMBLGrant #BataviaChromaTanAlliance #viralvector #CDMO #Bioprocessing #AAV

🌟 Explore our Viral Vector Expertise at Booth 344! 🌟 Are you at the Festival of Biologics in San Diego, USA from April 15-17, 2024? Explore our cutting-edge viral vector development and manufacturing services and innovations at Booth 344. Let's delve into how our specialized skills can propel your product development to the next level. See you there! 👋 #FestivalofBiologics #ViralVectors #Booth344 #CDMO #DrugManufacturing #viralvectors #viralvaccine #genetherapy #celltherapy #BataviaBiosciences #ScientificBreakthrough

🎉 We're thrilled to share this significant milestone in the fight against Lassa fever with you! 🎉 In Nigeria, participants have successfully received doses of a Lassa fever vaccine candidate, marking the launch of the first Phase 2 clinical trial for any Lassa vaccine. This pioneering effort, supported by IAVI and funded by CEPI (Coalition for Epidemic Preparedness Innovations), represents a crucial step forward in combating Lassa fever, a devastating hemorrhagic fever endemic to West Africa, yet lacking an approved vaccine. Batavia Biosciences proudly produced this Phase 2 clinical product using our innovative HIP-Vax manufacturing platform. 🔬 Innovation: HIP-Vax® leverages cutting-edge bioprocess intensification technologies, streamlining production timelines, reducing labor and consumables, and minimizing facility footprint – all critical elements in accelerating vaccine development. 💉 Vaccine Manufacturing: We're immensely proud to have manufactured IAVI's LASV vaccine candidate at our facility in Leiden, The Netherlands, demonstrating our dedication to delivering sustainable and robust manufacturing solutions in the fight against infectious diseases. Stay tuned for updates as we continue to work tirelessly towards a safer, healthier world for all. Together, we can make a difference! 💪 #LassaFever #VaccineDevelopment #GlobalHealth #CDMO #bioprocessing #BataviaBiosciences #IAVI #CEPI

🌟 Heading to Bioprocess International Europe in Vienna, Austria? Don't miss the chance to connect with us ! 🌟 𝗕𝗼𝗼𝘁𝗵 𝟯𝟭𝟬 Are you eager to bring your drug therapy from the bench to the bedside? Meet us at Bioprocess International Europe from April 9-12, 2024, and discover how our Contract Development and Manufacturing Organization can accelerate your product development trajectory. See you there! 👋 #BioprocessEurope #CDMO #DrugManufacturing #Booth310

🔬 Our Latest Scientific Paper is Out! Batavia Biosciences Unveils Revolutionary Polio Vaccine Quality Control Method! 🔬 The wait is over. We are thrilled to announce that our latest scientific paper has been published in the prestigious peer-reviewed journal, Vaccine. This paper marks a significant milestone in polio vaccine quality control. 👏 Congratulations to all authors for this amazing work! Lizet Opmeer, Isabella Gazzoli, Mónika Ballmann, Marieke Willemsen, Menzo Havenga, Chris Yallop, Ahd Hamidi, Gert Gillissen, Wilfried Bakker. 📝 "High throughput AS LNA qPCR method for the detection of a specific mutation in poliovirus vaccine strains " At Batavia Biosciences, we are dedicated to combat infectious diseases through scientific innovation. Our team's tireless efforts have led to the development of a groundbreaking qPCR method designed specifically for poliovirus vaccine quality control. 💡 Key Innovations: 𝗖𝘂𝘁𝘁𝗶𝗻𝗴-𝗲𝗱𝗴𝗲 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 : Our method leverages high-throughput AS LNA qPCR technology, offering sensitivity and accuracy in detecting mutations critical for quality control in vaccine. 𝗦𝘁𝗿𝗲𝗮𝗺𝗹𝗶𝗻𝗲𝗱 𝗤𝘂𝗮𝗹𝗶𝘁𝘆 𝗖𝗼𝗻𝘁𝗿𝗼𝗹 : By providing a rapid and cost-effective solution, our method enhances the efficiency of polio vaccine production ensuring quality. 𝗣𝗲𝗲𝗿-𝗥𝗲𝘃𝗶𝗲𝘄𝗲𝗱 𝗩𝗮𝗹𝗶𝗱𝗮𝘁𝗶𝗼𝗻 : The acceptance of our paper in Vaccine journal underscores the rigor and credibility of our research, affirming the reliability and efficacy of our innovative approach. We are proud to share our findings with the scientific community and contribute to the ongoing efforts to make a lasting impact in global health! 👉 Read the news here: https://lnkd.in/ef9eM7-B #BataviaBiosciences #bioprocessing #CDMO #ScientificBreakthrough #PolioVaccine #QualityControl #HealthcareInnovation 🔬

🌟 Join us at the World Vaccine Congress in Washington, DC! 🌟 Don't miss the presentation "High cell density and cost-effective manufacturing of viral vectors" by our Managing Director, Peter Abbink, Ph.D. Presentation Details: 📌April 3, 2024 🕐13:10 📍 Room 209 A-B Let's discuss how we can revolutionize viral vector manufacturing together! See you there! 👋 Booth 215 #WorldVaccineCongress #ViralVectors #Booth215

🌟 Exciting announcement! Batavia Biosciences and Candel Therapeutics collaborate to develop therapeutics against glioma brain tumors. 🌟 The collaboration aims to accelerate the development and production of CAN-3110, an oncolytic viral immunotherapy for glioma brain tumors, based on a replication attenuated Herpes Simplex Virus (HSV). 🧬 Batavia will use its HIP-Vax® technology to develop a highly intensified, scalable and robust manufacturing process for Candel. This work will establish a GMP-compatible process for the upcoming clinical trials. Read the full press release here: https://zurl.co/Fq5H #pressrelease #CDMO #bioprocessing #viralvector #HSV #braintumor #innovation #immunotherapy